The Gross Margin of SK Biopharmaceuticals Co Ltd (326030.KS) is 92.13%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 92.13% |
2023-12-31 | 90.40% |
2022-12-31 | 84.66% |
2021-12-31 | 94.66% |
2020-12-31 | 92.41% |
2019-12-31 | 99.58% |
2018-12-31 | 100.00% |
2017-12-31 | 4.19% |